Moreover, our data highlight that RAD18 is required for PCNA monoubiquitination upon HU treatment as detected by immunoblotting, consistent with our finding that PCNA ubiquitination at the K164 residue promotes fork recovery in BRCA1-deficient cancer cells. This evidence concerns the gene RAD18 and cancer.